We examine clinically validated biomarkers including amino acids, biogenic amines, acylcarnitines, carbohydrates and lipids.

Our scientific team pioneered the concept of “Inborn-Like Errors of Metabolism™”— as conditions that mimic congenital enzyme imbalances that now offer the opportunity for early detection and intervention before irreversible end-organ damage has occurred. 

These principles support metabolic interpretation across a wide clinical spectrum including:
•    Metabolic syndrome and insulin resistance
•    Cardiovascular and neurodegenerative disease
•    Sleep and mood disorders
•    Immune dysfunction and autoimmunity
•    Aging and longevity biology

Our MetaSync Analysis^TM test provides high-resolution biocemical profiling through LC-MS/MS and FIA-MS/MS, enabling actionable interpretation of core pathways in nutrition, mitochondrial function, detoxification, immune response, and aging.

By analyzing metabolites from patient plasma, we generate unique biochemical fingerprints that inform:
•    Nutritional assessment & metabolic individuality
•    Baseline status for oncology, chronic illness, or performance optimization
•    Longevity strategies & anti-aging interventions
•    Recovery and metabolic rebalancing during cancer therapy

The platform is validated against the NIST SRM-1950 human plasma standard and >3,000 clinical samples with age-, sex-, and BMI-adjusted reference values.

This test goes far beyond standard routine medical blood testing.

This provides the opportunity for intervention to design individualized recommendations for diet, supplementation, lifestyle and behavior.